Skip to contentV
Vycor Medical Inc
V
VYCOVycor Medical Inc Q3 2014 · 10-Q
Revenue$334.34K$334.34K+4.0% vs Q3 2013 Net Income-$1.28M-$1.28MN/M vs Q3 2013 EPS Diluted-$0.12-$0.12N/M vs Q3 2013 Gross Profit$286,999+2.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vycor Medical Inc · CIK 1424768 · Engraved from SEC EDGAR
Operating Cash Flowderived-$374,772N/M Free Cash Flowderived-$420,419N/M Margins · derivedGross margin85.8%−1.2 pt vs Q3 2013
Operating margin-130.9%+19.6 pt vs Q3 2013
Net margin-383.7%−226.1 pt vs Q3 2013
ended Sep 30, 2014 · filed Nov 12, 2014 · 43 d after period end